TREK™ 1012278-30Recalls & reported problems
Abbott Vascular Inc. · TREK™ Coronary Dilatation Catheter 4.0 mm x 30 mm / Rapid-Exchange · Class 2
All models of TREK (50)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 11
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI 08717648138744), received between Feb 9, 2017 and Jun 13, 2024 — classified as 5 injuries, 6 malfunctions.
The most frequently reported specific device problem is “Difficult to Remove” (7 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult to Remove7
- Off-Label Use7
- Material Separation6
- Improper or Incorrect Procedure or Method5
- Material Rupture3
- Deflation Problem2
- Detachment Of Device Component1
- Difficult to Advance1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Consequences Or Impact To Patient5
- Device Embedded In Tissue or Plaque1
Recent adverse event reports
The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 13, 2024Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method; Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION THE RIGHT CORONARY ARTERY (RCA). THE 4.0X30MM TREK RX BALLOON DILATATION CATHETER (BDC) WAS INFLATED WITHOUT ISSUES AND DEFLATED FOR REMOVAL. HOWEVER, THE DISTAL PORTION BROKE OFF WHEN IT HAD RESISTANCE WITH THE GUIDE CATHETER AND SLIGHT FORCE WAS APPLIED BUT SEPARATED PORTION WAS NOTED TO BE IN THE GUIDE WIRE SO THE GUIDE WIRE WAS SIMPLY REMOVED. THE PROCEDURE WAS COMPLETED AT THIS TIME. THERE WAS NO ADVERSE PATIENT EFFECT AND THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19533883 ↗MalfunctionJun 22, 2023Off-Label Use; Material Rupture; Off-Label Use; Material Rupture
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A 90% STENOSED LESION IN THE PULMONARY ARTERY. A 4.00X30MM TREK RX BALLOON DILATATION CATHETER (BDC) WAS ADVANCED AND INFLATED ONE TIME TO 6 ATMOSPHERES (ATM) WHEN A BALLOON RUPTURE OCCURRED. THE BDC WAS REMOVED, AND A SECOND, SAME SIZE TREK BDC WAS ADVANCED. THE SECOND BALLOON WAS INFLATED ONE TIME TO 6 ATMOSPHERES (ATM) WHEN THIS BALLOON RUPTURED AS WELL. A THIRD, SAME SIZE TREK BDC WAS USED WITHOUT ISSUE TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO REPORTED ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAYS IN THE PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17182877 ↗MalfunctionJun 22, 2023Off-Label Use; Material Rupture; Off-Label Use; Material Rupture
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A 90% STENOSED LESION IN THE PULMONARY ARTERY. A 4.00X30MM TREK RX BALLOON DILATATION CATHETER (BDC) WAS ADVANCED AND INFLATED ONE TIME TO 6 ATMOSPHERES (ATM) WHEN A BALLOON RUPTURE OCCURRED. THE BDC WAS REMOVED, AND A SECOND, SAME SIZE TREK BDC WAS ADVANCED. THE SECOND BALLOON WAS INFLATED ONE TIME TO 6 ATMOSPHERES (ATM) WHEN THIS BALLOON RUPTURED AS WELL. A THIRD, SAME SIZE TREK BDC WAS USED WITHOUT ISSUE TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO REPORTED ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAYS IN THE PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17182876 ↗InjuryJun 24, 2022Off-Label Use; Difficult to Remove; Material Separation; Off-Label Use; Difficult to Remove; Material Separation
IT WAS REPORTED THAT THIS WAS A PROCEDURE, PERFORMED TO TREAT A TARGET LESION IN THE LOWER EXTREMITY. THE UNSPECIFIED TREK DILATATION CATHETER WAS USED; HOWEVER, DURING REMOVAL, THE BALLOON SEPARATED. THREE SNARE DEVICES WERE USED TO REMOVE THE SEPARATED SEGMENT AND PULL IT INTO THE SHEATH. THE SHEATH AND SEPARATED BALLOON SEGMENT WERE REMOVED. THE SHEATH WAS REPLACED AND THE PROCEDURE WAS CONTINUED AND COMPLETED WITHOUT ANY ADDITIONAL ISSUES. THERE WAS NO ADVERSE PATIENT SEQUELA OR A CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14811405 ↗InjuryDec 20, 2021Off-Label Use; Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method; Off-Label Use; Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LEFT TIBIAL ARTERY. TWO 4X30MM TREK BALLOONS WERE USED IN THE SAME PROCEDURE. BOTH WERE INFLATED TWICE AT 12 ATMOSPHERES WITHOUT ISSUES. HOWEVER, THE FIRST TREK BALLOON DURING REMOVAL RESISTANCE WAS MET WHEN THE BALLOON SEPARATED AND WAS THEN SUCCESSFULLY SNARED OUT. FOR THE SECOND TREK BALLOON, DURING REMOVAL RESISTANCE WAS MET WHEN THE BALLOON SEPARATED AND WAS LEFT IN THE BODY AND CRUSHED AGAINST THE ARTERY WITH A STENT. RESISTANCE DURING REMOVAL FOR BOTH BALLOONS WAS MET WITH AN UNSPECIFIED SOURCE. ANOTHER NON-ABBOTT BALLOON WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT SEQUELA AND NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13044520 ↗InjuryDec 20, 2021Off-Label Use; Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method; Off-Label Use; Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LEFT TIBIAL ARTERY. TWO 4X30MM TREK BALLOONS WERE USED IN THE SAME PROCEDURE. BOTH WERE INFLATED TWICE AT 12 ATMOSPHERES WITHOUT ISSUES. HOWEVER, THE FIRST TREK BALLOON DURING REMOVAL RESISTANCE WAS MET WHEN THE BALLOON SEPARATED AND WAS THE SUCCESSFULLY SNARED OUT. FOR THE SECOND TREK BALLOON, DURING REMOVAL RESISTANCE WAS MET WHEN THE BALLOON SEPARATED AND WAS LEFT IN THE BODY AND CRUSHED AGAINST THE ARTERY WITH A STENT. RESISTANCE DURING REMOVAL FOR BOTH BALLOONS WAS MET WITH AN UNSPECIFIED SOURCE. ANOTHER NON-ABBOTT BALLOON WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO ADVERSE PATIENT SEQUELA AND NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Device Embedded In Tissue or Plaque
MAUDE report 13044454 ↗MalfunctionApr 14, 2020Deflation Problem; Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method; Deflation Problem; Difficult to Remove; Material Separation; Improper or Incorrect Procedure or Method
RETURNED DEVICE ANALYSIS IDENTIFIED THE SHAFT WAS SEPARATED. THE ACCOUNT CONFIRMED THAT THIS OCCURRED AFTER USE AND WAS DUE TO REMOVING THE CATHETER FROM THE INTRODUCER SHEATH. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9958999 ↗MalfunctionFeb 26, 2020Off-Label Use; Material Rupture; Difficult to Advance; Off-Label Use; Material Rupture; Difficult to Advance
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A HEAVILY CALCIFIED LESION IN THE RIGHT COMMON CAROTID ARTERY. A 5X30MM RX VIATRAC PLUS BALLOON DILATATION CATHETER (BDC) MET RESISTANCE WITH THE HEAVY CALCIFICATION DURING ADVANCEMENT AND RUPTURED AT 5 ATMOSPHERES DURING THE FIRST INFLATION. A 4.0X30MM TREK RX BDC ALSO MET RESISTANCE DURING ADVANCEMENT AND RUPTURED AT 10 ATMOSPHERES DURING THE FIRST INFLATION. AN 8X25MM NON-ABBOTT STENT WAS THEN IMPLANTED AND POST-DILATED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9759451 ↗InjuryAug 7, 2019Deflation Problem; Off-Label Use; Difficult to Remove; Material Separation; Deflation Problem; Off-Label Use; Difficult to Remove; Material Separation
SUBSEQUENT TO THE INITIALLY FILED MEDWATCH REPORT, RETURN ANALYSIS NOTED AN UNKNOWN WHISPER GUIDE WIRE RETURNED FROZEN IN THE GUIDE WIRE LUMEN OF THE RX TREK CATHETER. THE POLYMER COATING WAS NOTED TO BE DAMAGED. PER THE ACCOUNT, THE POLYMER DAMAGE LIKELY OCCURRED DURING THE ATTEMPT TO REMOVE THE SEPARATED PORTION OF THE RX TREK. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8870490 ↗InjuryFeb 2, 2018Detachment Of Device Component; Inflation Problem; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE MODERATE TO HEAVILY CALCIFIED, 80% STENOSED TIBIOPERONEAL (TP TRUNK) ARTERY. A 4.00 X 30 MM TREK RX BALLOON DILATATION CATHETER (BDC) WAS SELECTED FOR THE PROCEDURE. THE BDC WAS ADVANCED WITH NO RESISTANCE FELT TO THE LESION AND THE BALLOON WOULD NOT INFLATE. DURING REMOVAL OF THE BDC FROM THE ANATOMY ONLY A PORTION OF THE SHAFT CAME OUT OF THE PATIENT. IT WAS OBSERVED THAT THE DISTAL PORTION OF THE SHAFT WITH THE BALLOON HAD SEPARATED FROM THE HYPOTUBE PORTION OF THE SHAFT. SEVERAL UNSUCCESSFUL ATTEMPTS WITH VARIOUS METHODS INCLUDING BALLOON ENTRAPMENT, SINGLE LOOP SNARE AND A TRI-LOOP SNARE OF VARIOUS SIZES WERE MADE TO RETRIEVE THE SEPARATED DISTAL PORTION OF THE BDC FROM THE ANATOMY. THE PATIENT WAS SENT TO SURGERY TO HAVE THE SEPARATED DISTAL PORTION WITH THE BALLOON REMOVED FROM THE ANATOMY. THE PATIENT WAS TAKEN TO THE ICU POST-PROCEDURE. ON (B)(6) 2018 THE PATIENT WAS TAKEN BACK TO THE CATH LAB WHERE A SUCCESSFUL INTERVENTION WAS PERFORMED ON THE RIGHT SUPERFICIAL FEMORAL ARTERY (SFA). NO ADDITIONAL INFORMATION PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7235360 ↗MalfunctionFeb 9, 2017Difficult to Remove
IT WAS REPORTED THIS WAS AN EMERGENT PROCEDURE TO TREAT A 100% CLOTTED SAPHENOUS GRAFT TO THE OBTUSE MARGINAL. A THROMBECTOMY WITH ANGIOJET WAS PERFORMED. THEN, THE TREK RX 4.0 X 30 MM BALLOON DILATATION CATHETER WAS ADVANCED OVER THE XT FIELDER GUIDE WIRE AND INFLATED 3 TIMES TO 14 ATMOSPHERES BUT WHEN THE TREK RX WAS BEING REMOVED, IT FROZE ON THE WIRE. THE BALLOON WAS FULLY DEFLATED PRIOR TO REMOVAL. BOTH DEVICES WERE REMOVED AS A SINGLE UNIT. THERE WAS NO REPORTED RESISTANCE DURING REMOVAL OF THE STYLET OR PROTECTIVE SHEATH. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6315865 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page